Roivant Sciences Ltd.
ROIV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001635088
In the last 90 days, Roivant Sciences Ltd. insiders filed 0 open-market purchases and 11 sales; 500 institutions reported holding it in 13F filings for Q2 2026, worth $19.7B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.
Holders of 5% or more of ROIV
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Roivant Sciences Ltd., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 13G/A | 10.30%73.6M shares | +2.10 ppfrom 8.20% | Aug 6, 20252 filings | Mar 6, 2026 | SEC |
| Ramaswamy Vivek | 13G/A | 6.80%48.4M shares | −4.83 ppfrom 11.63% | May 15, 20253 filings | Feb 13, 2026 | SEC |
| Morgan Stanley | 13G | 5.50%37.6M shares | New | Aug 7, 20251 filing | Aug 7, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
15 Schedule 13D and 13G filings on Roivant Sciences Ltd., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 27, 20261:02 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Mar 6, 202610:05 AM ET | FMR LLCand 1 other | 13G/A | 10.30%73.6M shares | +2.10 ppfrom 8.20% | Feb 27, 2026 | SEC |
| Feb 17, 20265:00 PM ET | SB Investment Advisers (UK) Ltdand 3 others | 13G/A | 2.30%16.4M shares | −3.50 ppfrom 5.80%Below 5% | Dec 31, 2025 | SEC |
| Feb 13, 20263:32 PM ET | Ramaswamy Vivek | 13G/A | 6.80%48.4M shares | −4.83 ppfrom 11.63% | Dec 31, 2025 | SEC |
| Nov 14, 20254:54 PM ET | Viking Global Investors LPand 12 othersSuperinvestorViking Global Investors | 13G/A | 3.40%23.6M shares | −1.62 ppfrom 5.02%Below 5% | Sep 30, 2025 | SEC |
| Nov 14, 20254:30 PM ET | SB Investment Advisers (UK) Ltdand 3 others | 13G/A | 5.80%40.3M shares | −2.70 ppfrom 8.50% | Sep 30, 2025 | SEC |
| Aug 14, 20255:32 PM ET | Viking Global Investors LPand 12 othersSuperinvestorViking Global Investors | 13G/A | 5.02%34.2M shares | −1.38 ppfrom 6.40% | Jun 30, 2025 | SEC |
| Aug 14, 20254:39 PM ET | QVT Financial LP | 13G/A | 4.30%29.4M shares | −4.92 ppfrom 9.22%Below 5% | Jun 30, 2025 | SEC |
| Aug 7, 20253:04 PM ET | Morgan Stanleyand 1 other | 13G | 5.50%37.6M shares | New | Jun 30, 2025 | SEC |
| Aug 6, 202512:11 PM ET | FMR LLCand 1 other | 13G/A | 8.20%55.5M shares | – | Jun 30, 2025 | SEC |
| May 15, 20256:53 PM ET | Ramaswamy Vivek | 13G/A | 11.63%83.0M shares | +0.43 ppfrom 11.20% | Mar 31, 2025 | SEC |
| May 15, 20255:29 PM ET | Ramaswamy Vivek | 13G/A | 11.20%83.0M shares | – | Dec 31, 2024 | SEC |
| May 15, 20254:35 PM ET | Viking Global Investors LPand 12 othersSuperinvestorViking Global Investors | 13G/A | 6.40%46.0M shares | – | Mar 31, 2025 | SEC |
| Feb 14, 20252:00 PM ET | QVT Financial LP | 13G/A | 9.22%65.8M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 20259:59 AM ET | SB Investment Advisers (UK) Ltdand 3 others | 13G/A | 8.50%62.1M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Roivant Sciences Ltd. shares.
No Form 144 notices for Roivant Sciences Ltd. are on file.